ES2361808B8 - Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. - Google Patents
Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. Download PDFInfo
- Publication number
- ES2361808B8 ES2361808B8 ES200930203A ES200930203A ES2361808B8 ES 2361808 B8 ES2361808 B8 ES 2361808B8 ES 200930203 A ES200930203 A ES 200930203A ES 200930203 A ES200930203 A ES 200930203A ES 2361808 B8 ES2361808 B8 ES 2361808B8
- Authority
- ES
- Spain
- Prior art keywords
- diagnosis
- useful data
- obtaining useful
- forecast
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.#La presente invención se encuadra dentro del campo de la biomedicina. Específicamente, se refiere a un método de obtención de datos útiles para el diagnóstico, el pronóstico o la monitorización de la evolución de un cáncer colorrectal (CCR), a un método de diagnóstico de un CCR, a un método de pronóstico de un CCR ya un kit para llevar a cabo dichos métodos.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200930203A ES2361808B8 (es) | 2009-05-25 | 2009-05-25 | Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. |
AU2010252907A AU2010252907B2 (en) | 2009-05-25 | 2010-05-25 | Methods for the diagnosis or prognosis of colorectal cancer |
ES10730815.7T ES2551713T3 (es) | 2009-05-25 | 2010-05-25 | Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal |
US13/322,303 US20120101003A1 (en) | 2009-05-25 | 2010-05-25 | Methods for the diagnosis or prognosis of colorectal cancer |
PCT/ES2010/070350 WO2010136629A1 (es) | 2009-05-25 | 2010-05-25 | Métodos para el diagnóstico o pronóstico del cáncer colorrectal |
EP10730815.7A EP2444811B1 (en) | 2009-05-25 | 2010-05-25 | Methods for the diagnosis or prognosis of colorectal cancer |
CA2763557A CA2763557C (en) | 2009-05-25 | 2010-05-25 | Methods for the diagnosis or prognosis of colorectal cancer |
PL10730815T PL2444811T3 (pl) | 2009-05-25 | 2010-05-25 | Sposoby diagnozowania lub prognozowania raka jelita grubego |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200930203A ES2361808B8 (es) | 2009-05-25 | 2009-05-25 | Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. |
Publications (3)
Publication Number | Publication Date |
---|---|
ES2361808A1 ES2361808A1 (es) | 2011-06-22 |
ES2361808B1 ES2361808B1 (es) | 2012-05-16 |
ES2361808B8 true ES2361808B8 (es) | 2012-11-29 |
Family
ID=42542763
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200930203A Expired - Fee Related ES2361808B8 (es) | 2009-05-25 | 2009-05-25 | Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. |
ES10730815.7T Active ES2551713T3 (es) | 2009-05-25 | 2010-05-25 | Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10730815.7T Active ES2551713T3 (es) | 2009-05-25 | 2010-05-25 | Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal |
Country Status (7)
Country | Link |
---|---|
US (1) | US20120101003A1 (es) |
EP (1) | EP2444811B1 (es) |
AU (1) | AU2010252907B2 (es) |
CA (1) | CA2763557C (es) |
ES (2) | ES2361808B8 (es) |
PL (1) | PL2444811T3 (es) |
WO (1) | WO2010136629A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9766253B2 (en) | 2012-07-30 | 2017-09-19 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies |
US20160333418A1 (en) * | 2014-01-14 | 2016-11-17 | Santa Maria Biotherapeutics, Inc. | Activin Inhibitor Response Prediction and Uses for Treatment |
CN104777310A (zh) * | 2015-01-23 | 2015-07-15 | 郑振海 | 一种肿瘤相关抗体定量检测试剂盒 |
ES2619116B1 (es) * | 2015-12-23 | 2018-04-12 | Fundación Para La Investigación Biomédica Del Hospital Universitario 12 De Octubre | Biomarcador para el diagnóstico, pronóstico y seguimiento de cáncer colorrectal de aparición precoz |
CN110456069A (zh) * | 2019-07-31 | 2019-11-15 | 四川大学华西医院 | Zap70自身抗体检测试剂在制备肺癌筛查试剂盒中的用途 |
CN110488014A (zh) * | 2019-08-27 | 2019-11-22 | 成都和同易创生物科技有限公司 | 一种检测结直肠癌转移潜能的试剂盒及其使用方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060275851A1 (en) * | 2000-07-26 | 2006-12-07 | Emmert-Buck Michael R | Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples |
US20030148314A1 (en) * | 2001-08-01 | 2003-08-07 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
WO2006056766A2 (en) * | 2004-11-24 | 2006-06-01 | St George's Enterprises Limited | Diagnosis of prostate cancer |
AU2006259583A1 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
US9347945B2 (en) * | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
JP2010509598A (ja) * | 2006-11-13 | 2010-03-25 | ライフ テクノロジーズ コーポレーション | 前立腺癌バイオマーカーを検出するための方法およびキット |
AU2009270793A1 (en) * | 2008-07-18 | 2010-01-21 | Oragenics, Inc. | Compositions for the detection and treatment of colorectal cancer |
-
2009
- 2009-05-25 ES ES200930203A patent/ES2361808B8/es not_active Expired - Fee Related
-
2010
- 2010-05-25 AU AU2010252907A patent/AU2010252907B2/en active Active
- 2010-05-25 PL PL10730815T patent/PL2444811T3/pl unknown
- 2010-05-25 CA CA2763557A patent/CA2763557C/en active Active
- 2010-05-25 EP EP10730815.7A patent/EP2444811B1/en active Active
- 2010-05-25 ES ES10730815.7T patent/ES2551713T3/es active Active
- 2010-05-25 US US13/322,303 patent/US20120101003A1/en not_active Abandoned
- 2010-05-25 WO PCT/ES2010/070350 patent/WO2010136629A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20120101003A1 (en) | 2012-04-26 |
CA2763557C (en) | 2019-04-23 |
EP2444811B1 (en) | 2015-08-05 |
EP2444811A1 (en) | 2012-04-25 |
ES2361808A1 (es) | 2011-06-22 |
ES2551713T3 (es) | 2015-11-23 |
ES2361808B1 (es) | 2012-05-16 |
PL2444811T3 (pl) | 2016-01-29 |
WO2010136629A9 (es) | 2011-01-20 |
CA2763557A1 (en) | 2010-12-02 |
AU2010252907B2 (en) | 2016-03-17 |
AU2010252907A1 (en) | 2012-01-12 |
WO2010136629A1 (es) | 2010-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL254062B (en) | Kits containing ptk7 antibody and their use in the treatment, detection, diagnosis or monitoring of cancer | |
ES2644277T3 (es) | Métodos de diagnóstico para determinar la prognosis del cáncer de pulmón de células no pequeñas | |
EA201390149A1 (ru) | Способы выявления заболевания или патологических состояний с использованием фагоцитарных клеток | |
BR112014009643A2 (pt) | métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal | |
WO2014160499A3 (en) | Methods and compositions for detecting pancreatic cancer | |
WO2011095623A3 (en) | miRNA IN THE DIAGNOSIS OF OVARIAN CANCER | |
HK1187377A1 (zh) | 用於對乳腺癌的轉移進行診斷、預後和治療的方法 | |
EP2539470A4 (en) | METHODS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES | |
WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
EP2684157A4 (en) | SYSTEM AND METHOD FOR IMAGING OF DOUBLE ENERGY AND / OR INJECTION BREAST OF A CONTRAST AGENT FOR SCREENING, DIAGNOSIS AND BIOPSY | |
BRPI1006075A2 (pt) | biomarcadores de cancer | |
ZA201300519B (en) | Novel antibody for the diagnosis and/or prognosis of cancer | |
GB2513275B (en) | Biomarkers for Breast Cancer Prediction and Diagnosis | |
HK1213946A1 (zh) | 用於使用 對***癌轉移進行診斷、預後和治療的方法 | |
WO2013066369A3 (en) | Methods for detecting graft-versus-host disease | |
DK2900279T3 (da) | Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer | |
ES2361808B8 (es) | Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal. | |
WO2014078468A3 (en) | Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent | |
EP2723866A4 (en) | METHOD FOR THE PROGNOSIS AND / OR DIAGNOSIS OF NEURODEEGENERATIVE DISEASES, METHOD FOR IDENTIFYING COMPOUND CANDIDATES AND COMPOUNDS FOR THE TREATMENT OF NEURODEGENATIVE DISEASES | |
EP2988131A4 (en) | Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof | |
GB2533872B (en) | Biomarkers useful for detection of types, grades and stages of human breast cancer | |
HK1211345A1 (en) | Methods of prognosis and diagnosis of cancer | |
EP2780476A4 (en) | METHOD FOR DIAGNOSIS AND / OR FORECASTING GYNECOLOGICAL CARCINOMA | |
IT1398262B1 (it) | Sonda ad ultrasuoni. | |
HK1174955A1 (en) | Detecting pax2 for the diagnosis of breast cancer pax2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA2A | Application withdrawn |
Effective date: 20110110 |
|
FG2A | Definitive protection |
Ref document number: 2361808 Country of ref document: ES Kind code of ref document: B1 Effective date: 20120516 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20210915 |